OBJECTIVES: The NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) was developed to assess symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We assessed the responsiveness of the NIH-CPSI to change over time and defined thresholds for changes perceptible to patients. METHODS: We studied 174 men with CP/CPPS who participated in aplacebo-controlled randomized clinical trial. Changes from baseline to six weeks in the NIH-CPSI total score and pain, urinary, and quality of life subscores were compared to a global response assessment (GRA). Effect sizes and Guyatt statistics were calculated to evaluate responsiveness; 95% confidence intervals were produced using bootstrapping. RESULTS: All scores decreased over time with the largest decrease in subjects who reported on the GRA that they were markedly improved. The NIH-CPSI total, pain, and quality of life scores were highly responsive in the improved groups; the urinary score showed minimal responsiveness. There was no evidence of responsiveness among those subjects who worsened on the trial. ROC curves identified a 6-point decline in the NIH-CPSI total score as the optimal threshold to predict treatment response. CONCLUSIONS: The NIH-CPSI total score and pain and quality of life subscores are responsive to change over time.
RCT Entities:
OBJECTIVES: The NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) was developed to assess symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We assessed the responsiveness of the NIH-CPSI to change over time and defined thresholds for changes perceptible to patients. METHODS: We studied 174 men with CP/CPPS who participated in a placebo-controlled randomized clinical trial. Changes from baseline to six weeks in the NIH-CPSI total score and pain, urinary, and quality of life subscores were compared to a global response assessment (GRA). Effect sizes and Guyatt statistics were calculated to evaluate responsiveness; 95% confidence intervals were produced using bootstrapping. RESULTS: All scores decreased over time with the largest decrease in subjects who reported on the GRA that they were markedly improved. The NIH-CPSI total, pain, and quality of life scores were highly responsive in the improved groups; the urinary score showed minimal responsiveness. There was no evidence of responsiveness among those subjects who worsened on the trial. ROC curves identified a 6-point decline in the NIH-CPSI total score as the optimal threshold to predict treatment response. CONCLUSIONS: The NIH-CPSI total score and pain and quality of life subscores are responsive to change over time.
Authors: M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary Journal: J Urol Date: 1999-08 Impact factor: 7.450
Authors: M McNaughton Collins; M A Pontari; M P O'Leary; E A Calhoun; J Santanna; J R Landis; J W Kusek; M S Litwin Journal: J Gen Intern Med Date: 2001-10 Impact factor: 5.128
Authors: Richard B Alexander; Kathleen J Propert; Anthony J Schaeffer; J Richard Landis; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton-Collins; Daniel A Shoskes; Craig V Comiter; Nand S Datta; Jackson E Fowler; Robert B Nadler; Scott I Zeitlin; Jill S Knauss; Yanlin Wang; John W Kusek; Leroy M Nyberg; Mark S Litwin Journal: Ann Intern Med Date: 2004-10-19 Impact factor: 25.391
Authors: M M Collins; M P O'Leary; E A Calhoun; M A Pontari; A Adler; S Eremenco; C H Chang; L Odom; M S Litwin Journal: J Urol Date: 2001-11 Impact factor: 7.450
Authors: Michel A Pontari; John N Krieger; Mark S Litwin; Paige C White; Rodney U Anderson; Mary McNaughton-Collins; J Curtis Nickel; Daniel A Shoskes; Richard B Alexander; Michael O'Leary; Scott Zeitlin; Shannon Chuai; J Richard Landis; Liyi Cen; Kathleen J Propert; John W Kusek; Leroy M Nyberg; Anthony J Schaeffer Journal: Arch Intern Med Date: 2010-09-27
Authors: J Curtis Nickel; Richard B Alexander; Rodney Anderson; Richard Berger; Craig V Comiter; Nand S Datta; Jackson E Fowler; John N Krieger; J Richard Landis; Mark S Litwin; Mary McNaughton-Collins; Michael P O'Leary; Michel A Pontari; Anthony J Schaeffer; Daniel A Shoskes; Paige White; John Kusek; Leroy Nyberg Journal: Curr Urol Rep Date: 2008-07 Impact factor: 3.092
Authors: J Curtis Nickel; John N Krieger; Mary McNaughton-Collins; Rodney U Anderson; Michel Pontari; Daniel A Shoskes; Mark S Litwin; Richard B Alexander; Paige C White; Richard Berger; Robert Nadler; Michael O'Leary; Men Long Liong; Scott Zeitlin; Shannon Chuai; J Richard Landis; John W Kusek; Leroy M Nyberg; Anthony J Schaeffer Journal: N Engl J Med Date: 2008-12-18 Impact factor: 91.245
Authors: J Q Clemens; E A Calhoun; M S Litwin; M McNaughton-Collins; R L Dunn; E M Crowley; J R Landis Journal: Prostate Cancer Prostatic Dis Date: 2009-06-02 Impact factor: 5.554